Superiority of Tandem Autologous Transplantation Over Standard Therapy for Previously Untreated Multiple Myeloma
Data up to Jan 2025
Total Citations Per Year
Abstract
References (18)
GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR TO HARVEST CIRCULATING HAEMOPOIETIC STEM CELLS FOR AUTOTRANSPLANTATION
1989 • 776 citations
Effective Treatment of Advanced Multiple Myeloma Refractory to Alkylating Agents
1984 • 667 citations
Graft-versus-myeloma effect: proof of principle
1996 • 565 citations
HIGH-DOSE INTRAVENOUS MELPHALAN FOR PLASMA-CELL LEUKAEMIA AND MYELOMA
1983 • 515 citations
Poor prognosis in multiple myeloma is associated only with partial or complete deletions of chromosome 13 or abnormalities involving 11q and not with other karyotype abnormalities
1995 • 418 citations
Prognostic factors in allogeneic bone marrow transplantation for multiple myeloma.
1995 • 301 citations
Multiple myeloma: significance of plasmablastic subtype in morphological classification
1985 • 249 citations
Graft-versus-myeloma effect in two cases
1996 • 245 citations
Low-risk intensive therapy for multiple myeloma with combined autologous bone marrow and blood stem cell support
1992 • 177 citations
Low-risk intensive therapy for multiple myeloma with combined autologous bone marrow and blood stem cell support
1992 • 143 citations
Combination chemotherapy, glucocorticoids, and interferon alfa in the treatment of multiple myeloma: a Southwest Oncology Group study.
1994 • 139 citations
Increased incidence of second neoplasms in patients treated with interferon alpha 2b for hairy cell leukemia: a clinicopathologic assessment [see comments]
1994 • 114 citations
Interferon alfa‐2b versus no maintenance therapy during the plateau phase in multiple myeloma: a randomized study
1995 • 96 citations
Etoposide, dexamethasone, cytarabine, and cisplatin in vincristine, doxorubicin, and dexamethasone-refractory myeloma.
1989 • 65 citations
Chemotherapy is superior to sequential hemibody irradiation for remission consolidation in multiple myeloma: a Southwest Oncology Group study.
1990 • 57 citations
Response to interferon therapy in patients with multiple myeloma correlates with expression of the Bcl‐2 oncoprotein
1995 • 40 citations
Maintenance therapy for remission in myeloma with Intron A following high-dose melphalan and either an autologous bone marrow transplantation or peripheral stem cell rescue.
1995 • 36 citations
Multiple myeloma: significance of plasmablastic subtype in morphological classification
1985 • 24 citations
Cited By (0)
No citing papers found in database